ORCID

Document Type

Article

Abstract

Background Second-hand smoke (SHS) exposure remains a major source of morbidity and mortality among non-smokers. This study presents the first dedicated Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) publication to systematically quantify SHS prevalence and evaluate its effect as a global risk factor across a broader range of outcomes. Methods Using the GBD 2023 comparative risk assessment framework, we estimated SHS exposure prevalence and attributable disease burden across 204 countries and territories from 1990 to 2023, stratified by age and sex. Exposure estimates were derived by synthesising population-based surveys and household composition data through spatiotemporal Gaussian process regression. Relative risks for nine health outcomes, now including asthma, were estimated using the Burden of Proof methodology, and applied to calculate attributable deaths and disability-adjusted life-years (DALYs). Findings In 2023, an estimated 2·71 billion (95% UI 2·44–3·02) people worldwide were exposed to SHS, including 767 million (687–858) children aged 0–14 years. Age-standardised prevalence was highest in southeast Asia, east Asia, and Oceania (48·4% [44·0–53·4]), with female individuals in some countries experiencing nearly 1·8 times the exposure prevalence of male individuals. Despite a 22·2% (10·6–32·4) decline in global age-standardised prevalence since 1990, this progress has not been sufficient to reduce the absolute number of exposed individuals, which has remained stable globally and has risen sharply in sub-Saharan Africa (98·5% [62·0–144·4] increase) and North Africa and the Middle East (72·1% [47·8–101·8] increase). In 2023, SHS exposure accounted for 1·66 million (1·33–2·07) deaths and 44·8 million (35·8–54·3) DALYs globally. Ischaemic heart disease was the leading contributor to SHS-attributable DALYs (12·0 million [9·31–15·2]) overall, while lower respiratory infections predominated among children (5·16 million [3·48–7·12]). Interpretation We estimated that SHS remains a substantial driver of global health loss, particularly through cardiovascular and paediatric respiratory diseases. Persistent geographical disparities and growing absolute numbers of exposed individuals in several regions underscore the urgent need for accelerated implementation and enforcement of comprehensive tobacco control measures, particularly to protect women and children in both public and domestic environments. Funding Bloomberg Philanthropies and the Gates Foundation.

Publication Date

2026-09-07

Publication Title

The Lancet Public Health

Volume

11

Issue

10

Deposit Date

2026-09-22

Funding

This paper was developed as part of the GBD Collaborator Network and GBD Protocol with support from the GBD Secretariat, Institute for Health Metrics and Evaluation (IHME), and the GBD Collaborator Network under the IHME identification number 6096. This study was funded by Bloomberg Philanthropies and the Gates Foundation. This paper was checked with the assistance of Claude (version Sonnet 4.5, Anthropic, San Francisco, CA, USA) for a series of Lancet, GBD, and IHME compliance issues, including formatting guidelines, word counts, spelling, grammar, British English conventions, and middle-dot notation. AI was not used in the drafting of original content, data analysis, or interpretation of results. All scientific judgements, interpretations, and editorial decisions are those of the named authors, who take full responsibility for the content of the paper. This paper was developed as part of the GBD Collaborator Network and GBD Protocol with support from the GBD Secretariat, Institute for Health Metrics and Evaluation (IHME), and the GBD Collaborator Network under the IHME identification number 6096. This study was funded by Bloomberg Philanthropies and the Gates Foundation. This paper was checked with the assistance of Claude (version Sonnet 4.5, Anthropic, San Francisco, CA, USA) for a series of Lancet, GBD, and IHME compliance issues, including formatting guidelines, word counts, spelling, grammar, British English conventions, and middle-dot notation. AI was not used in the drafting of original content, data analysis, or interpretation of results. All scientific judgements, interpretations, and editorial decisions are those of the named authors, who take full responsibility for the content of the paper. Editorial note: The Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations.

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

First Page

767

Last Page

785

Share

COinS